IL17A and atherosclerosis: Propolis proved to be a significant inhibitor of IL-6 in experimental models of inflammation and, in addition, the study of Fang et al., 2013 proved that propolis decreased the level of IL-6 while increasing IL-17 in a rodent model of dyslipidemia and atherosclerosis [71].